Optimi Health Secures Amendment to Increase Quantities Of MDMA, MDA, And 2C-B Under Controlled Drugs And Substances Dealer’s Licence Optimi Health granted amendment to its Health Canada Controlled Drugs and Substances Licence.

Vantage Hemp Co. Submits Drug Master File for CBD Isolate to the U.S. Food & Drug Administration Greeley, Colorado, April 04, 2023 (GLOBE NEWSWIRE) -- Vantage Hemp Co. (“Vantage” or the “Company”) announces that it has submitted a Drug Master File (DMF) for its cannabidiol (CBD) Isolate to the...

Global $250+ Bn Pharmaceutical API Manufacturing (Chemical & Biological) Markets, 2016-2021, 2021-2026F, 2031F Dublin, April 13, 2022 (GLOBE NEWSWIRE) -- The "Pharmaceutical API Manufacturing Global Market Report 2022: By Therapy, By API, By Drug" report has been added to ResearchAndMarkets.com's offering. ...

Vantage Hemp Co. is in the Final Stages of its DMF Submissions Greeley, Colorado, Jan. 24, 2022 (GLOBE NEWSWIRE) -- Vantage Hemp Co. (“Vantage” or the “Company”), an industry-leading manufacturer of pharmaceutical-grade CBD products, today announced that the...